Sebastian Preissl

Current Position

Deputy Professor, Group Leader

Academic Education

2010	German licensure as pharmacist
2009 - 2010	Diploma in Pharmacy, European ScreeningPort GmbH, Hamburg, Germany and Institute for Pharmaceutical Sciences, University of Freiburg, Germany
2004 - 2009	Study of Pharmacy, University of Freiburg, Germany

Advanced Qualifications

2010-2015

PhD, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany

Postgraduate Positions

2021 - present	Deputy Professor, Group Leader, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany
2017-2021	Associate Director, Single Cell Genomics, Center for Epigenomics, UCSD, La Jolla, CA, USA
2015-2017	Postdoctoral Fellow, Ludwig Institute for Cancer Research, La Jolla, CA, USA
2015	Postdoctoral Fellow, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany

Link to all publications of Sebastian Preissl: PubMed

Publications on CRC 1453 funding

Schröder CM, Zissel L, Mersiowsky SL, …, Schüle KM, Preissl S, Schilling O, Timmers M, Arnold S. EOMES establishes mesoderm and endoderm differentiation potential through SWI/SNF-mediated global enhancer remodeling. Dev Cell (2024). Mahajan A, Spracklen CN, Zhang W, Ng MCY, Petty LE, …, Wuttke M, …, Preissl S, …, Köttgen A, …, Rotter JI, McCarthy MI, Morris AP. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet (2022).